Autor: |
Michael Vaeggemose, Rosa Andersen Mencagli, Julie Schjødtz Hansen, Bianca Dräger, Steffen Ringgaard, John Vissing, Henning Andersen |
Jazyk: |
angličtina |
Rok vydání: |
2021 |
Předmět: |
|
Zdroj: |
PeerJ, Vol 9, p e10928 (2021) |
Druh dokumentu: |
article |
ISSN: |
2167-8359 |
DOI: |
10.7717/peerj.10928 |
Popis: |
Background Pompe Disease (PD) is a rare inherited metabolic myopathy, caused by lysosomal-α-glucosidase (GAA) deficiency, which leads to glycogen accumulation within the lysosomes, resulting in cellular and tissue damage. Due to the emergence of a disease modifying treatment with recombinant GAA there has been a large increase in studies of late onset Pompe Disease (LOPD) during the last decade. Methods The present study evaluates muscle quality in 10 patients with LOPD receiving treatment with enzyme replacement therapy and in 10 age and gender matched healthy controls applying T1-weighted Dixon MR imaging and isokinetic dynamometry. Muscle quality was determined by muscle strength in relation to muscle size (contractile cross-sectional area, CSA) and to muscle quality (fat fraction). A follow-up evaluation of the patients was performed after 8–12 months. Patient evaluations also included: six-minute walking test (6MWT), forced vital capacity, manual muscle testing and SF-36 questionnaire. Results Fat fraction of knee flexors (0.15 vs 0.07, p |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|